# Specification Quality Checklist: Clinical ML Kit Framework

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-10-15
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- Validation pass 1: all items pass.
- No [NEEDS CLARIFICATION] markers were used. The user explicitly asked that unresolved clinical
  and data questions be listed rather than resolved; they are recorded in the spec's "Open Items"
  section and are resolved through the defined approval/verification processes (FR-032, FR-071,
  FR-081, FR-082), not by clarification before planning.
- "Non-technical stakeholders": the spec necessarily uses clinical-ML vocabulary (leakage,
  calibration, cohort) because its audience is instructors and reviewers in that domain; it
  contains no technology choices.
- Dataset names (All of Us, PTB-XL, ISIC, TCIA, MedMNIST) are user-specified scope, not
  implementation details.
- Open Item 6 (reference-kit prediction types) and Open Item 9 (export out of restricted
  environments) are the most likely to affect Milestones 3–4; consider `/speckit-clarify` on them
  before `/speckit-plan`.
